AdvanSix (ASIX) to Release Earnings on Friday

AdvanSix (NYSE:ASIX) is expected to post its Q4 2025 results before the market opens on Friday, February 20th. Analysts expect AdvanSix to post earnings of ($0.06) per share and revenue of $340.85 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 20, 2026 at 9:30 AM ET.

AdvanSix Stock Down 2.0%

Shares of AdvanSix stock opened at $18.48 on Friday. AdvanSix has a 1 year low of $14.10 and a 1 year high of $31.03. The firm has a market cap of $496.32 million, a price-to-earnings ratio of 9.62 and a beta of 1.72. The company has a 50-day moving average of $17.17 and a 200 day moving average of $18.35. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.36 and a quick ratio of 0.74.

Hedge Funds Weigh In On AdvanSix

A number of institutional investors have recently bought and sold shares of the stock. Bridgeway Capital Management LLC raised its holdings in AdvanSix by 0.9% during the second quarter. Bridgeway Capital Management LLC now owns 264,433 shares of the company’s stock valued at $6,280,000 after acquiring an additional 2,394 shares during the period. Verition Fund Management LLC boosted its position in shares of AdvanSix by 186.5% during the 3rd quarter. Verition Fund Management LLC now owns 31,031 shares of the company’s stock valued at $601,000 after acquiring an additional 20,199 shares during the last quarter. Russell Investments Group Ltd. grew its stake in shares of AdvanSix by 4.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 252,345 shares of the company’s stock worth $4,890,000 after buying an additional 11,681 shares in the last quarter. Creative Planning grew its position in AdvanSix by 273.0% in the third quarter. Creative Planning now owns 44,618 shares of the company’s stock worth $865,000 after acquiring an additional 32,657 shares in the last quarter. Finally, Qube Research & Technologies Ltd lifted its position in AdvanSix by 24.8% in the third quarter. Qube Research & Technologies Ltd now owns 69,245 shares of the company’s stock worth $1,342,000 after buying an additional 13,754 shares during the last quarter. 86.39% of the stock is owned by institutional investors.

Analyst Ratings Changes

ASIX has been the topic of a number of analyst reports. Truist Financial initiated coverage on AdvanSix in a research report on Thursday, January 15th. They issued a “hold” rating and a $19.00 price target on the stock. Weiss Ratings reissued a “sell (d+)” rating on shares of AdvanSix in a report on Monday, December 29th. Finally, Wall Street Zen cut AdvanSix from a “hold” rating to a “sell” rating in a research note on Friday, January 23rd. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $28.67.

AdvanSix Company Profile

AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.

The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.